Presented at Thessaloniki 2024, on the 26th of June, 2024.
Moderator: Ed Carlson (⚑ United States) - CEO Odyssey House Louisiana
Jason Kew - Police – Going Soft on drugs
Gemma Yarwood - Dying well: the void...
Presented at Thessaloniki 2024, on the 26th of June, 2024.
Justice systems are evolving to incorporate treatment and care, along with accountability, as an alternative to incarceration (ATI) for people with substance use...
Presented at Thessaloniki 2024, on the 26th of June, 2024.
Increasingly, recovery from a substance use disorder is being recognized as a distinct point on the continuum of care for someone affected by a substance use...
Presented at Thessaloniki 2024, on the 26th of June, 2024.
Moderator: Ms. Vivienne Evans (⚑ United Kingdom) - ADFAM
Vivienne Evans - The Role of the Family in Recovery
David Best - Building Inclusive Recovery...
Presented at Thessaloniki 2024, on the 26th of June, 2024.
Moderator: Ms. Sue Thau (⚑ United States) - CADCA - ISSUP Board Member
Robert Balster, Hala Najm and Olajumoke Koyejo - The Hubert H. Humphrey Fellowship...
The Art of Healing 2024 Opening Ceremony, presented in Thessaloniki on the 26th of June, 2024, with Joanna Travis Roberts and Kevin Mulvey.
Teachers act as a driving force in drug prevention. But in non-evidence-based prevention approaches, the teacher will be a collector of negative results or null results rather than a positive result in drug prevention. The officers of the...
New Orleans, June 14-18, 2025
The CPDD meeting is an in-person meeting with no digital participation options.
Symposium, Mini-Symposium, Workshop, and Forum
Deadline: Friday, October 18, 2024
The Fogarty International Center of the U.S. National Institutes of Health (NIH) and partner organizations will host a Global Forum on Humanitarian Health Research (GFH2R) inclusive of public webinars and an in-person meeting in May 2025...
Chronic non-cancer pain (CNCP) is one of the most common causes of disability globally. Opioid prescribing to treat CNCP remains widespread, despite limited evidence of long-term clinical benefit and...
The COVID-19 pandemic has impacted how people access medications for opioid dependence. Researchers looked at monthly changes in several factors related to buprenorphine/naloxone (BNX) treatment over 56 months, including...
The study analyzed national data from the U.S. to track trends in cannabis use from 2013 to 2021, focusing on changes in use among young and middle-aged adults. Researchers also looked at whether these trends varied by sociodemographic...
The World Health Organization (WHO) uses risk drinking levels (low, moderate, high, and very high risk) as a measure for reducing alcohol consumption in clinical trials. However, these levels have not been specifically evaluated for...
This study aimed to explore how exposure to digital advertising for alcohol and cannabis might impact the likelihood of young adults driving under the influence of these substances. The researchers investigated the associations between...
This study looks at how certain factors in research can skew the results when estimating the health effects of drinking small amounts of alcohol. These biases can affect public health advice and shape how people view alcohol’s potential...
Panel presented at Thessaloniki 2024: Joining Together in Action with the Global Coalition to Address Synthetic Drug Threats, on the 26th of June, 2024.
Moderator: Ms. Margaret H. Nardi (⚑ United States) - Deputy Assistant Secretary...
Overdose Resource Exchange (ORE) is a central collection of CDC-reviewed communication materials and educational resources about opioid misuse, addiction, treatment, and overdose prevention for state, territorial, and local health...
This guide was drawn from HEALing Communities Study (HCS) learnings to-date and expert insights to provide guidance regarding implementation of ORCCA menu strategies.
